TY - JOUR
T1 - Parental age and the risk of childhood acute myeloid leukemia
T2 - results from the Childhood Leukemia International Consortium
AU - FRECCLE group
AU - NARECHEM-ST group
AU - Panagopoulou, Paraskevi
AU - Skalkidou, Alkistis
AU - Marcotte, Erin
AU - Erdmann, Friederike
AU - Ma, Xiaomei
AU - Heck, Julia E.
AU - Auvinen, Anssi
AU - Mueller, Beth A.
AU - Spector, Logan G.
AU - Roman, Eve
AU - Metayer, Catherine
AU - Magnani, Corrado
AU - Pombo-de-Oliveira, Maria S.
AU - Scheurer, Michael E.
AU - Mora, Ana Maria
AU - Dockerty, John D.
AU - Hansen, Johnni
AU - Kang, Alice Y.
AU - Wang, Rong
AU - Doody, David R.
AU - Kane, Eleanor
AU - Schüz, Joachim
AU - Christodoulakis, Christos
AU - Ntzani, Evangelia
AU - Petridou, Eleni Th
PY - 2019/4/1
Y1 - 2019/4/1
N2 - Background: Parental age has been associated with several childhood cancers, albeit the evidence is still inconsistent. Aim: To examine the associations of parental age at birth with acute myeloid leukemia (AML) among children aged 0–14 years using individual-level data from the Childhood Leukemia International Consortium (CLIC) and non-CLIC studies. Material/methods: We analyzed data of 3182 incident AML cases and 8377 controls from 17 studies [seven registry-based case-control (RCC) studies and ten questionnaire-based case-control (QCC) studies]. AML risk in association with parental age was calculated using multiple logistic regression, meta-analyses, and pooled-effect estimates. Models were stratified by age at diagnosis (infants <1 year-old vs. children 1–14 years-old) and by study design, using five-year parental age increments and controlling for sex, ethnicity, birthweight, prematurity, multiple gestation, birth order, maternal smoking and education, age at diagnosis (cases aged 1–14 years), and recruitment time period. Results: Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) derived from RCC, but not from the QCC, studies showed a higher AML risk for infants of mothers ≥40-year-old (OR = 6.87; 95% CI: 2.12–22.25). There were no associations observed between any other maternal or paternal age group and AML risk for children older than one year. Conclusions: An increased risk of infant AML with advanced maternal age was found using data from RCC, but not from QCC studies; no parental age-AML associations were observed for older children.
AB - Background: Parental age has been associated with several childhood cancers, albeit the evidence is still inconsistent. Aim: To examine the associations of parental age at birth with acute myeloid leukemia (AML) among children aged 0–14 years using individual-level data from the Childhood Leukemia International Consortium (CLIC) and non-CLIC studies. Material/methods: We analyzed data of 3182 incident AML cases and 8377 controls from 17 studies [seven registry-based case-control (RCC) studies and ten questionnaire-based case-control (QCC) studies]. AML risk in association with parental age was calculated using multiple logistic regression, meta-analyses, and pooled-effect estimates. Models were stratified by age at diagnosis (infants <1 year-old vs. children 1–14 years-old) and by study design, using five-year parental age increments and controlling for sex, ethnicity, birthweight, prematurity, multiple gestation, birth order, maternal smoking and education, age at diagnosis (cases aged 1–14 years), and recruitment time period. Results: Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) derived from RCC, but not from the QCC, studies showed a higher AML risk for infants of mothers ≥40-year-old (OR = 6.87; 95% CI: 2.12–22.25). There were no associations observed between any other maternal or paternal age group and AML risk for children older than one year. Conclusions: An increased risk of infant AML with advanced maternal age was found using data from RCC, but not from QCC studies; no parental age-AML associations were observed for older children.
KW - Childhood cancer
KW - Epidemiology
KW - Infant acute myeloid leukemia
KW - Maternal age
KW - Paternal age
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=85061603212&partnerID=8YFLogxK
U2 - 10.1016/j.canep.2019.01.022
DO - 10.1016/j.canep.2019.01.022
M3 - Article
AN - SCOPUS:85061603212
SN - 1877-7821
VL - 59
SP - 158
EP - 165
JO - Cancer Epidemiology
JF - Cancer Epidemiology
ER -